Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF‐C/VEGFR‐3 signalling pathway
- 4 May 2016
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 173 (12) , 1966-1987
Abstract
Background and Purpose: Lymphangiogenesis is an important biological process associated with the pathogenesis of several diseases, including metastatic dissemination, graft rejection, lymphoedema and other inflammatory disorders. The development of new drugs that block lymphangiogenesis has become a promising therapeutic strategy. In this study, we investigated the ability of toluquinol, a 2‐methyl‐hydroquinone isolated from the culture broth of the marine fungus Penicillium sp. HL‐85‐ALS5‐R004, to inhibit lymphangiogenesis in vitro, ex vivo and in vivo.Experimental Approach: We used human lymphatic endothelial cells (LECs) to analyse the effect of toluquinol in 2D and 3D in vitro cultures and in the ex vivo mouse lymphatic ring assay. For in vivo approaches, the transgenic Fli1:eGFPy1 zebrafish, mouse ear sponges and cornea models were used. Western blotting and apoptosis analyses were carried out to search for drug targets.Key Results: Toluquinol inhibited LEC proliferation, migration, tubulogenesis and sprouting of new lymphatic vessels. Furthermore, toluquinol induced apoptosis of LECs after 14 h of treatment in vitro, blocked the development of the thoracic duct in zebrafish and reduced the VEGF‐C‐induced lymphatic vessel formation and corneal neovascularization in mice. Mechanistically, we demonstrated that this drug attenuates VEGF‐C‐induced VEGFR‐3 phosphorylation in a dose‐dependent manner and suppresses the phosphorylation of Akt and ERK1/2.Conclusions and Implications: Based on these findings, we propose toluquinol as a new candidate with pharmacological potential for the treatment of lymphangiogenesis‐related pathologies. Notably, its ability to suppress corneal neovascularization paves the way for applications in vascular ocular pathologies.Keywords
This publication has 58 references indexed in Scilit:
- Lymphatic vascular morphogenesis in development, physiology, and diseaseJournal of Cell Biology, 2011
- Immense Essence of Excellence: Marine Microbial Bioactive CompoundsMarine Drugs, 2010
- Animal research: Reporting in vivo experiments: The ARRIVE guidelinesBritish Journal of Pharmacology, 2010
- Cell Signaling by Receptor Tyrosine KinasesCell, 2010
- Deguelin—An inhibitor to tumor lymphangiogenesis and lymphatic metastasis by downregulation of vascular endothelial cell growth factor‐D in lung tumor modelInternational Journal of Cancer, 2010
- Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma modelBritish Journal of Cancer, 2009
- Liposomal honokiol inhibits VEGF‐D‐induced lymphangiogenesis and metastasis in xenograft tumor modelInternational Journal of Cancer, 2009
- Potential therapeutic strategies for lymphatic metastasisMicrovascular Research, 2007
- In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitroNature Protocols, 2007
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006